Home » NOVAVAX EXECUTES AGREEMENT FOR $38 MILLION SECONDARY PUBLIC OFFERING
NOVAVAX EXECUTES AGREEMENT FOR $38 MILLION SECONDARY PUBLIC OFFERING
Novavax Inc. announced that it
has entered into a definitive agreement for a $38 million registered direct offering
of 5,205,479 shares of its common stock at a price of $7.30 per share. The shares
of common stock will be issued pursuant to an effective shelf registration statement.
Small
Times
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May